Daniel Eriksson

Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis

Craig I Coleman, Reinhold Kreutz, Nitesh Sood et al. · The American Journal of Medicine · 2019 · 119 citations

Thrombosis, Hemodialysis, Cardiovascular Disease +10

Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis

Nicole Hannemann, Shan Cao, Daniel Eriksson et al. · Journal of Clinical Investigation · 2019 · 102 citations · Full text

Immunology, Immune Regulation, Innate Immunity +21

Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia

Daniel Eriksson, David Goldsmith, S Teitsson et al. · BMC Nephrology · 2016 · 99 citations · Full text

Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes

Adrían V. Hernández, G. Bradley, Mohammad Khan et al. · European Heart Journal - Quality of Care and Clinical Outcomes · 2019 · 65 citations

Rivaroxaban’s Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis

Craig I Coleman, Reinhold Kreutz, Nitesh Sood et al. · Clinical and Applied Thrombosis/Hemostasis · 2019 · 57 citations · Full text

Cardiovascular Pharmacology, Dialysis Therapy, Pharmacotherapy +19